Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan M Whitaker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Annals of Thoracic Surgery|January 26, 2021
Cancer Database Analyses Require Cautious Interpretation, Careful ApproachRyan M Whitaker, Neil B Newman, Evan C Osmundson
Toxicology Letters|November 27, 2013
Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosisL Jay Stallons, Ryan M Whitaker, Rick G Schnellmann
Annual Review of Pharmacology and Toxicology|November 14, 2015
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic DiseasesRyan M Whitaker, Daniel Corum, Craig C Beeson, et al.
The Journal of Biological Chemistry|November 23, 2016
Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological ConditionsJustin B Collier, Ryan M Whitaker, Scott T Eblen, et al.
Cureus|October 8, 2024
Split-Course Adaptive Radioimmunotherapy for Oligometastatic Non-Small Cell Lung Cancer (SiCARIO): A Case ReportKyra N McComas, Sarah E Masick, Adam D Yock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2013
cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injuryRyan M Whitaker, Lauren P Wills, L Jay Stallons, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injurySara M Garrett, Ryan M Whitaker, Craig C Beeson, et al.
JAMA Network Open|April 22, 2024
Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung CancerMeghan J Mooradian, Ling Cai, Alice Wang, et al.
Journal of Neurotrauma|June 21, 2016
Striatal Mitochondrial Disruption following Severe Traumatic Brain InjuryJennifer L Harmon, Whitney S Gibbs, Ryan M Whitaker, et al.
ACS Chemical Biology|May 23, 2012
Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cellsMatthew A Smith, Campbell McInnes, Ryan M Whitaker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Annals of Thoracic Surgery|January 26, 2021
Cancer Database Analyses Require Cautious Interpretation, Careful ApproachRyan M Whitaker, Neil B Newman, Evan C Osmundson
Toxicology Letters|November 27, 2013
Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosisL Jay Stallons, Ryan M Whitaker, Rick G Schnellmann
Annual Review of Pharmacology and Toxicology|November 14, 2015
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic DiseasesRyan M Whitaker, Daniel Corum, Craig C Beeson, et al.
The Journal of Biological Chemistry|November 23, 2016
Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological ConditionsJustin B Collier, Ryan M Whitaker, Scott T Eblen, et al.
Cureus|October 8, 2024
Split-Course Adaptive Radioimmunotherapy for Oligometastatic Non-Small Cell Lung Cancer (SiCARIO): A Case ReportKyra N McComas, Sarah E Masick, Adam D Yock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2013
cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injuryRyan M Whitaker, Lauren P Wills, L Jay Stallons, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injurySara M Garrett, Ryan M Whitaker, Craig C Beeson, et al.
JAMA Network Open|April 22, 2024
Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung CancerMeghan J Mooradian, Ling Cai, Alice Wang, et al.
Journal of Neurotrauma|June 21, 2016
Striatal Mitochondrial Disruption following Severe Traumatic Brain InjuryJennifer L Harmon, Whitney S Gibbs, Ryan M Whitaker, et al.
ACS Chemical Biology|May 23, 2012
Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cellsMatthew A Smith, Campbell McInnes, Ryan M Whitaker, et al.
Pageof 2